Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - Chronic Obstructive Pulmonary Disease
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

alex.hogeland@engagehealthmedia.com

Considerations in Treating Relapsing Multiple Sclerosis During Pregnancy

Considerations in Treating Relapsing Multiple Sclerosis During Pregnancy

expert roundtables
By Robert A. Bermel, MD, MBA; Fred D. Lublin, MD; Robert T. Naismith, MD

Outcome Measures for Patients With Relapsing Multiple Sclerosis

Outcome Measures for Patients With Relapsing Multiple Sclerosis

expert roundtables
By Robert A. Bermel, MD, MBA; Fred D. Lublin, MD; Robert T. Naismith, MD

Considering the Role of Measurable Residual Disease in Chronic Lymphocytic Leukemia

Considering the Role of Measurable Residual Disease in Chronic Lymphocytic Leukemia

expert roundtables
By Alessandra Ferrajoli, MD; Nitin Jain, MD; David G. Maloney, MD, PhD

Personalized Treatment Selection for Patients With Relapsing Multiple Sclerosis

Personalized Treatment Selection for Patients With Relapsing Multiple Sclerosis

expert roundtables
By Robert A. Bermel, MD, MBA; Fred D. Lublin, MD; Robert T. Naismith, MD

The Individualized Selection and Sequencing of JAK Inhibitors for Myelofibrosis

The Individualized Selection and Sequencing of JAK Inhibitors for Myelofibrosis

clinical topic updates
By Andrew Kuykendall, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?